Dermatology

Latest News

FDA Sets Review Date for Zoryve in Atopic Dermatitis
FDA Sets Review Date for Zoryve in Atopic Dermatitis

November 29th 2023

The FDA has set a date of July 07, 2024, for Zorvye 0.15% for adults and children six and up with the chronic skin disease atopic dermatitis.

Dupixent Gets Complete Response Letter for Inflammatory Skin Disorder
Dupixent Gets Complete Response Letter for Inflammatory Skin Disorder

October 23rd 2023

Zoryve is Now Approved for Children with Plaque Psoriasis
Zoryve is Now Approved for Children with Plaque Psoriasis

October 6th 2023

Manufacturing Issues Lead to CRL for Liquid Botulinum Toxin
Manufacturing Issues Lead to CRL for Liquid Botulinum Toxin

October 4th 2023

FDA Issues CRL for Lebrikizumab in Atopic Dermatitis
FDA Issues CRL for Lebrikizumab in Atopic Dermatitis

October 2nd 2023

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.